SABSW SAB Biotherapeutics, Inc. - Warrant
$0,03
Prix · Aoû 18, 2026
Données fondamentales au Aoû 6, 2026
Fourchette 52 semaines
$0–$0
65% of range
Note des analystes
—
Objectif de cours
—
P/E (TTM)
-0.0
ROE
16.2%
Marge nette
—
SABSW Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$0.03
Capitalisation Boursière
$2M
P/E (TTM)
-0.0
BPA (TTM)
$-0.79
Revenus (TTM)
$0
Rendement div.
—
ROE
16.2%
Dette/Capitaux propres
0.0
Fourchette 52 semaines
$0 – $0
SABSW Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$0
2020-12-31
→
2025-12-31
BPA
$-0.79
2020-12-31
→
2025-12-31
Flux de trésorerie libre
$-46M
2021-12-31
→
2025-12-31
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
SABSW
Médiane des pairs
P/E (TTM)
-0.0
—
P/B
0.0
—
EV / EBITDA
2.1
—
Price / FCF (Cours / FCF)
-0.0
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
SABSW
Médiane des pairs
ROA
12.2%
—
ROE
16.2%
—
ROIC
-32.3%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
SABSW
Médiane des pairs
Debt / Equity (Dette / Capitaux propres)
0.0
—
Current Ratio (Ratio de liquidité)
9.5
—
Quick Ratio (Ratio de liquidité réduite)
9.0
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
SABSW
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
-40.9%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
-72.1%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
SABSW
Médiane des pairs
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $1M | $2M | $24M | $61M | $55M | |
| R&D Expense | $34M | $30M | $17M | $36M | $57M | $28M | |
| SG&A Expense | $15M | $14M | $24M | $16M | $17M | $7M | |
| Operating Expenses | $49M | $44M | $40M | $53M | $74M | $35M | |
| Operating Income | $-49M | $-43M | $-38M | $-29M | $-13M | $21M | |
| Interest Expense | · | · | $315.3K | $301.6K | $294.5K | $469.2K | |
| Other Non-op | $62M | $9M | $-4M | $10M | $5.5K | $4.0K | |
| Pretax Income | $13M | · | $-42M | $-19M | $-17M | $20M | |
| Income Tax | $0 | $0 | $0 | $25.6K | $0 | $0 | |
| Net Income | $13M | $-34M | $-42M | $-19M | $-17M | $20M | |
| EPS (Basic) | $0.22 | $-3.68 | $-7.64 | $-4.31 | $-0.63 | $0.79 | |
| EPS (Diluted) | $-0.79 | $-3.68 | $-7.64 | $-4.31 | $-0.63 | $0.74 | |
| Shares (Basic) | 19,311,798 | 9,261,918 | 5,521,487 | 4,352,497 | 27,339,180 | 25,391,084 | |
| Shares (Diluted) | 61,340,193 | 9,261,918 | 5,521,487 | 4,352,497 | 27,339,180 | 27,011,482 | |
| EBITDA | $-46M | $-38M | $-34M | · | $-12M | · |
Bilan 24
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $9M | $57M | $15M | $33M | $13M | |
| Short-term Investments | $86M | $12M | $0 | · | · | · | |
| Receivables | · | · | $0 | $6M | $8M | $21M | |
| Prepaid Expense | $4M | $3M | $2M | $1M | $3M | $1M | |
| Current Assets | $101M | $24M | $59M | $22M | $50M | $34M | |
| PP&E (Net) | $13M | $15M | $20M | $23M | $24M | $15M | |
| PP&E (Gross) | $31M | $30M | $30M | $30M | $28M | · | |
| Accum. Depreciation | $18M | $15M | $10M | $6M | $3M | $2M | |
| Total Assets | $173M | $44M | $84M | $51M | $81M | $57M | |
| Accounts Payable | $3M | $2M | $945.9K | $4M | $4M | $7M | |
| Accrued Liabilities | · | · | · | · | · | $156.2K | |
| Short-term Debt | $0 | $275.8K | $1M | $772.7K | $2M | $538.7K | |
| Current Liabilities | $11M | $8M | $11M | $15M | $26M | $11M | |
| Capital Leases | $2M | $581.1K | $635.8K | $361.2K | $2M | $2M | |
| Total Liabilities | $21M | $18M | $27M | $20M | $43M | $18M | |
| Total Debt | $0 | $275.8K | $1M | · | $2M | · | |
| Common Stock | $5.0K | $935 | $929 | $510 | $4.3K | $2.6K | |
| Paid-in Capital | $268M | $156M | $153M | $84M | $68M | $51M | |
| Retained Earnings | $-111M | $-124M | $-90M | $-48M | $-29M | $-12M | |
| Treasury Stock | $6M | $6M | $6M | $6M | $0 | · | |
| AOCI | $187.0K | $-135.4K | $26.4K | · | · | · | |
| Stockholders' Equity | $151M | $26M | $57M | $31M | $39M | $39M | |
| Liabilities + Equity | $173M | $44M | $84M | $51M | $81M | $57M | |
| Shares Outstanding | 47,609,899 | 9,288,868 | 9,225,494 | 5,040,236 | 43,487,279 | 25,973,406 |
Flux de trésorerie 12
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $3M | $5M | $4M | $3M | $1M | $383.1K | |
| Stock-based Comp | $5M | $3M | $2M | $3M | $2M | $1M | |
| Other Non-cash | $-66M | $-8M | $11M | · | $15M | · | |
| Operating Cash Flow | $-45M | $-34M | $-25M | $-23M | $2M | $10M | |
| CapEx | $933.2K | $337.3K | $197.2K | $2M | $11M | $13M | |
| Investing Cash Flow | $-122M | $-12M | $-152.7K | $-2M | $-11M | $-13M | |
| Stock Issued | · | · | · | $8M | $0 | $10M | |
| Net Stock Activity | · | · | · | · | $0 | · | |
| Financing Cash Flow | $168M | $-1M | $67M | $1M | $36M | $9M | |
| Net Change in Cash | $2M | $-48M | $42M | $-24M | $27M | $6M | |
| Free Cash Flow | $-46M | $-35M | $-25M | · | $-9M | · | |
| Levered FCF | · | · | $-26M | · | · | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | -3244.9% | -1700.6% | · | -22.0% | · | |
| Net Margin | · | -2579.0% | -1884.5% | · | -28.2% | · | |
| Pretax Margin | · | · | -1884.5% | · | -28.2% | · | |
| EBITDA Margin | · | -2889.0% | -1537.4% | · | -19.6% | · | |
| ROA | 12.2% | -53.2% | -62.6% | · | -17.2% | · | |
| ROE | 16.2% | -108.5% | -116.3% | · | -46.6% | · | |
| ROIC | -32.3% | · | -65.2% | · | · | · |
Liquidité et Solvabilité 4
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 9.5 | 3.0 | 5.4 | · | 1.9 | 0.3 | |
| Quick Ratio | 9.0 | 2.6 | 5.2 | · | 1.6 | 0.3 | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | · | 0.0 | · | |
| Interest Coverage | · | · | -120.8 | · | -45.5 | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.6 | · | |
| Receivables Turnover | · | · | 0.8 | · | 4.3 | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | -40.9% | -90.6% | -60.7% | 10.2% | · | |
| Revenue CAGR 3Y | · | -72.1% | -65.6% | · | · | · | |
| Net Income CAGR 5Y | -8.0% | · | · | · | · | · |
Valorisation (TTM) 12
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $1M | $2M | $24M | $61M | $55M | |
| Net Income TTM | $13M | $-34M | $-42M | $-19M | $-17M | $20M | |
| Market Cap | $1M | · | · | · | · | · | |
| Enterprise Value | $-95M | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | |
| P/B | 0.0 | · | · | · | · | · | |
| P / Tangible Book | 0.0 | · | · | · | · | · | |
| P / Cash Flow | -0.0 | · | · | · | · | · | |
| P / FCF | -0.0 | · | · | · | · | · | |
| EV / EBITDA | 2.1 | · | · | · | · | · | |
| EV / FCF | 2.1 | · | · | · | · | · | |
| Earnings Yield | -3390.6% | · | · | · | · | · |
Compte de résultat 15
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $114.7K | $0 | $263.1K | $944.6K | $305.0K | $1M | $85.5K | $581.1K | $2M | $4M | |
| R&D Expense | $16M | $13M | $11M | $9M | $7M | $8M | $7M | $8M | $7M | $8M | $4M | $4M | $4M | $5M | $7M | $7M | |
| SG&A Expense | $7M | $7M | $5M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $15M | $3M | $3M | $3M | $3M | $4M | |
| Operating Expenses | $23M | $20M | $16M | $13M | $10M | $11M | $10M | $11M | $10M | $12M | $19M | $7M | $7M | $8M | $10M | $11M | |
| Operating Income | $-23M | $-20M | $-16M | $-13M | $-10M | $-11M | $-10M | $-11M | $-10M | $-11M | $-19M | $-5M | $-6M | $-7M | $-8M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | $93.1K | $76.4K | · | $69.7K | $75.3K | $92.4K | $87.7K | $70.6K | |
| Other Non-op | $886.0K | $1M | $-1M | $58M | $-382.0K | $6M | $-1M | $960.0K | $3M | $6M | $-4M | $220.6K | $-404.3K | $48.2K | $11.0K | $731.2K | |
| Pretax Income | · | · | · | · | · | · | · | $-10M | $-7M | $-5M | · | $-5M | $-7M | $-7M | $-8M | $-7M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | |
| Net Income | $-22M | $-19M | $-17M | $45M | $-10M | $-5M | $-11M | $-10M | $-7M | $-5M | $-23M | $-5M | $-7M | $-7M | $-8M | $-7M | |
| EPS (Basic) | $-0.28 | $-0.35 | $1.37 | $0.50 | $-1.09 | $-0.56 | $-1.23 | $-1.12 | $-0.79 | $-0.54 | $-3.85 | $-0.97 | $-1.36 | $-1.46 | $-4.06 | $-0.16 | |
| EPS (Diluted) | $-0.28 | $-0.35 | $1.07 | $-0.21 | $-1.09 | $-0.56 | $-1.23 | $-1.12 | $-0.79 | $-0.54 | $-3.85 | $-0.97 | $-1.36 | $-1.46 | $-4.06 | $-0.16 | |
| Shares (Basic) | 79,753,100 | 53,558,639 | -9,934,812 | 10,660,500 | 9,294,469 | 9,291,641 | -18,494,239 | 9,259,192 | 9,255,025 | 9,241,940 | -9,800,944 | 5,240,600 | 5,042,126 | 5,039,705 | -124,791,154 | 43,030,885 | |
| Shares (Diluted) | 79,753,100 | 53,558,639 | -35,109,180 | 77,863,263 | 9,294,469 | 9,291,641 | -18,494,239 | 9,259,192 | 9,255,025 | 9,241,940 | -9,800,944 | 5,240,600 | 5,042,126 | 5,039,705 | -127,494,452 | 43,030,885 | |
| EBITDA | $-23M | $-19M | · | $-12M | $-9M | $-10M | · | $-10M | $-9M | $-9M | · | $-4M | $-6M | $-7M | · | $-7M |
Bilan 23
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $21M | $11M | $29M | $4M | $6M | $9M | $9M | $17M | $14M | $57M | $2M | $8M | $13M | $15M | $8M | |
| Short-term Investments | $94M | $87M | $86M | $81M | $2M | $7M | $12M | $21M | $20M | $30M | $0 | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $0 | $364.1K | $763.1K | $6M | · | |
| Prepaid Expense | $3M | $4M | $4M | $2M | $4M | $3M | $3M | $2M | $2M | $3M | $2M | $702.2K | $867.6K | $1M | $1M | $907.9K | |
| Current Assets | $108M | $113M | $101M | $113M | $9M | $16M | $24M | $33M | $40M | $47M | $59M | $3M | $9M | $15M | $22M | $22M | |
| PP&E (Net) | $14M | $14M | $13M | $13M | $14M | $15M | $15M | $16M | $17M | $18M | $20M | $21M | $22M | $22M | $23M | $24M | |
| PP&E (Gross) | $33M | $32M | $31M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $29M | |
| Accum. Depreciation | $19M | $18M | $18M | $17M | $16M | $15M | $15M | $14M | $13M | $12M | $10M | $9M | $8M | $7M | $6M | $5M | |
| Total Assets | $238M | $248M | $173M | $183M | $30M | $38M | $44M | $54M | $62M | $71M | $84M | $28M | $35M | $43M | $51M | $53M | |
| Accounts Payable | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $1M | $1M | $945.9K | $1M | $1M | $1M | $4M | $5M | |
| Short-term Debt | · | · | $0 | $0 | $0 | $138.6K | $275.8K | $0 | $615.8K | $835.5K | $1M | $541.6K | $111.9K | $444.5K | $772.7K | $25.0K | |
| Current Liabilities | $12M | $10M | $11M | $11M | $11M | $10M | $8M | $9M | $8M | $8M | $11M | $9M | $11M | $14M | $15M | $17M | |
| Capital Leases | $1M | $2M | $2M | $2M | $2M | $2M | $581.1K | $682.9K | $782.4K | $554.5K | $635.8K | $0 | $91.8K | $227.7K | $361.2K | $762.8K | |
| Total Liabilities | $23M | $21M | $21M | $18M | $18M | $17M | $18M | $17M | $16M | $19M | $27M | $13M | $16M | $18M | $20M | $22M | |
| Total Debt | · | · | · | $0 | $0 | $138.6K | · | $0 | $615.8K | $835.5K | · | $541.6K | $111.9K | $444.5K | · | $25.0K | |
| Common Stock | $8.0K | $7.6K | $4.8K | $4.8K | $936 | $936 | $935 | $929 | $929 | $929 | $929 | $5.3K | $5.3K | $5.1K | $510 | $4.4K | |
| Paid-in Capital | $373M | $363M | $268M | $265M | $157M | $156M | $156M | $155M | $154M | $153M | $153M | $88M | $87M | $85M | $84M | $76M | |
| Retained Earnings | $-152M | $-130M | $-111M | $-94M | $-139M | $-129M | $-124M | $-113M | $-102M | $-95M | $-90M | $-67M | $-62M | $-55M | $-48M | $-40M | |
| Treasury Stock | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| AOCI | $-930.0K | $-222.8K | $186.5K | $71.2K | $-15.8K | $-111.6K | $-135.4K | $52.1K | $-31.4K | $-63.4K | $26.4K | · | · | · | · | · | |
| Stockholders' Equity | $215M | $227M | $151M | $165M | $12M | $21M | $26M | $37M | $46M | $53M | $57M | $15M | $20M | $24M | $31M | $31M | |
| Liabilities + Equity | $238M | $248M | $173M | $183M | $30M | $38M | $44M | $54M | $62M | $71M | $84M | $28M | $35M | $43M | $51M | $53M | |
| Shares Outstanding | 83,493,068 | 75,744,576 | 47,609,899 | 47,493,994 | 9,291,697 | 9,291,697 | 9,288,868 | 9,229,274 | 9,229,274 | 9,229,274 | 9,225,494 | 52,319,156 | 52,314,656 | 50,397,762 | 5,040,236 | 43,030,885 |
Flux de trésorerie 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $800.0K | $731.0K | $738.2K | $700.0K | $800.0K | $756.6K | $842.7K | $900.0K | $1M | $2M | $854.7K | $1M | $900.0K | $898.5K | $893.2K | $890.0K | |
| Stock-based Comp | $7M | $5M | $3M | $800.8K | $627.2K | $613.0K | $674.1K | $1M | $601.4K | $617.4K | $536.9K | $639.2K | $644.8K | $602.8K | $628.5K | $578.2K | |
| Other Non-cash | · | $-2M | · | · | · | $-4M | · | · | · | $-8M | · | · | · | $4M | · | · | |
| Operating Cash Flow | $-10M | $-14M | $-17M | $-13M | $-7M | $-8M | $-10M | $-6M | $-8M | $-11M | $-13M | $-5M | $-5M | $-2M | $-2M | $-6M | |
| CapEx | $2M | $983.3K | · | · | · | · | $55.4K | $100.3K | $52.5K | $129.1K | $67.9K | $85.3K | $22.7K | $21.3K | $117.8K | $78.5K | |
| Investing Cash Flow | $-5M | $-66M | $-2M | $-130M | $5M | $5M | $9M | $-1M | $11M | $-31M | $-67.9K | $-40.9K | $-22.7K | $-21.3K | $-117.8K | $-78.5K | |
| Financing Cash Flow | $2M | $90M | $-41.7K | $169M | $-173.8K | $-174.0K | $217.0K | $-674.1K | $-321.0K | $-394.4K | $68M | $-140.3K | $-363.8K | $-359.8K | $8M | $-2M | |
| Net Change in Cash | $-12M | $10M | $-19M | $26M | $-2M | $-3M | $-273.2K | $-8M | $3M | $-43M | $54M | $-5M | $-5M | $-2M | $7M | $-8M | |
| Free Cash Flow | · | $-15M | · | · | · | · | · | · | · | $-11M | · | · | · | $-2M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -3877.0% | -1205.9% | · | -420.0% | -7573.4% | -1273.8% | · | -217.5% | |
| Net Margin | · | · | · | · | · | · | · | · | -2787.7% | -532.1% | · | -402.6% | -8046.1% | -1265.5% | · | -197.1% | |
| Pretax Margin | · | · | · | · | · | · | · | · | -2787.7% | -532.1% | · | -402.6% | -8046.1% | -1265.5% | · | -197.1% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -3496.9% | -998.1% | · | -344.2% | -6556.1% | -1119.2% | · | -192.8% | |
| ROA | -16.8% | -13.2% | · | 38.3% | -22.0% | -9.5% | · | -25.2% | -15.1% | -8.8% | · | -12.6% | -14.5% | -13.4% | · | -8.3% | |
| ROE | -19.8% | -15.2% | · | 45.0% | -34.8% | -14.0% | · | -39.7% | -22.3% | -13.0% | · | -22.2% | -24.2% | -22.4% | · | -66.3% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | · | -32.7% | -29.8% | · | · |
Liquidité et Solvabilité 4
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.2 | 11.4 | · | 10.5 | 0.9 | 1.7 | · | 3.7 | 5.2 | 5.7 | · | 0.3 | 0.8 | 1.1 | · | 1.3 | |
| Quick Ratio | 8.8 | 10.9 | · | 10.3 | 0.5 | 1.3 | · | 3.4 | 4.9 | 5.3 | · | 0.3 | 0.7 | 1.0 | · | 0.5 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -109.6 | -149.1 | · | -76.4 | -86.0 | -80.1 | · | -110.5 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | 0.5 | 1.5 | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $3M | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $6M | $11M | $22M | · | $36M | |
| Net Income TTM | $-6M | $11M | · | $20M | $-33M | $-28M | · | $-28M | $-24M | $-24M | · | $-26M | $-26M | $-18M | · | $-15M | |
| Market Cap | $3M | $3M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | 1.2 | 1.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -0.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / FCF | · | -0.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -5391.1% | -6173.2% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-06-30 | |
|---|---|---|---|---|---|
| Revenu | $0 | $1M | $2M | $24M | — |
| Marge d'exploitation % | — | -3244.9% | -1700.6% | — | — |
| Résultat net | $13M | $-34M | $-42M | $-19M | — |
| BPA dilué | $-0.79 | $-3.68 | $-7.64 | $-4.31 | — |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-06-30 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 0.0 | 0.0 | 0.0 | — | — |
| Ratio de liquidité | 9.5 | 3.0 | 5.4 | — | — |
| Ratio de liquidité réduite | 9.0 | 2.6 | 5.2 | — | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-06-30 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-46M | $-35M | $-25M | — | — |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 10 déclarants · $14K total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 2 (0 vs T. préc.) | 0 (-2 vs T. préc.) | 4 (+4 vs T. préc.) | 0 (-2 vs T. préc.) | +26K |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| LMR Partners LLP | $6 907 | 539 588 | 49,74% | Actions |
| CLEAR STREET LLC | $2 625 | 78 833 | 18,90% | Actions |
| MORGAN STANLEY | $1 874 | 146 439 | 13,50% | Actions |
| Clear Street Group Inc. | $1 012 | 79 033 | 7,29% | Actions |
| MILLENNIUM MANAGEMENT LLC | $800 | 62 500 | 5,76% | Option d'achat |
| GTS SECURITIES LLC | $537 | 41 301 | 3,87% | Actions |
| UBS Group AG | $85 | 6 567 | 0,61% | Actions |
| WOLVERINE ASSET MANAGEMENT LLC | $42 | 3 289 | 0,30% | Actions |
| TORONTO DOMINION BANK | $4 | 300 | 0,03% | Actions |
| Virtu Financial LLC | $0 | 21 223 | 0,00% | Actions |
Initiés de la société 1 initié · 1 dirigeants · 0 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Alexandra Kropotova | CHIEF MEDICAL OFFICER | 25 juin 2026 F | 42 308 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 3 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×2 dépôts | 10 août 2026 | 9,90% | Amendement | — | SEC |
| Christine Hamilton, Edward Hamilton | 1 novembre 2021 | — | Dépôt initial | Investissement passif | SEC |
| Eddie J. Sullivan, PhD | 1 novembre 2021 | — | Dépôt initial | Investissement passif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.